Comparative Effectiveness and Safety of Cariprazine and Lamotrigine in Patients of Bipolar Depression: A Prospective,Randomized,Open Label Study - Nil

A0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

研究概览

暂无简介。

•18-65 years of age, of either sex, with a principal diagnosis of Bipolar Depression based on ICD-10 & BDRS Screening, after receiving a written informed consent
•A physical examination, clinical laboratory and ECG with no significant clinical results

•1. History or current diagnosis of various axis I disorders other than Bipolar I disorder, suicide risk as observed using MADRS scale, risk of injury to self or others, organic disorders or mental retardation
•2. Patients of Unipolar depression
•3. Patients with 4 or more mood episodes in the prior 12 months or any current psychiatric diagnoses, including personality disorders of significant severity to interfere with the study besides Bipolar I depression
•4.History of allergic or autoimmune disorders
•5.Any major cardiovascular, renal or hepatic comorbidities/diseases
•6. Psychotropic drug use except eszopiclone, zolpidem, zopiclone,Chloral hydrate or zaleplon, lorazepam or diphenhydramine, benztropine or propranolol
•7. Women of childbearing potential having positive UPT
•8. Patients not willing to give consent for the study

发起方